APPLICATIONS: LIQUID BIOPSY
CHANGING THE FUTURE
Liquid Biopsy is an advanced yet simple alternative to surgical biopsies, enabling doctors to discover a range of information about a tumor at any stage through a simple blood sample. Instead of invasive tissue biopsies, DNA traces of cancer in the blood give clues about which type of cancer treatments work best for that patient and track the success of those treatments.
The Liquid Biopsy Process
THE FUTURE IN CANCER DIAGNOSIS AND TREATMENT EVALUATION
Long PROBE quickly “anchors” bringing the short PRIMER into close proximity with the DNA target
The DNA strands fold, allowing the CoDX™ short primer to bind
When the polymerase extends, the capture (probe) is cleaved, releasing the fluorophore
CoDX™ and Liquid Biopsy
EMPOWERING DOCTORS WITH LIFE IMPROVING DNA ANALYSIS
The enhanced specificity, SNP detection, and multiplex capabilities of Co-Diagnostics’ CoPrimers™makes them the ideal technology for liquid biopsy. Being able to better determine multiple distinct types of cancer present in a blood sample means earlier detection, more effective and affordable treatment, and improved patient compatibility with the treatment recommended by physicians.